US ph2 data not coming out till November. But we should rise going into it. I can't imagine the 14 million shares short can possibly confident it will be bad. I cant possibly see why it would show such blockbuster results in CKD, but nothing in pre dialysis. Of course Japan has already filed for pre-dialysis further encouraging my thesis.